These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22578367)

  • 1. Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.
    Desborough M; Stanworth S
    Transfusion; 2012 May; 52 Suppl 1():20S-9S. PubMed ID: 22578367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should plasma be transfused prophylactically before invasive procedures?
    Holland L; Sarode R
    Curr Opin Hematol; 2006 Nov; 13(6):447-51. PubMed ID: 17053457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of point-of-care testing for plasma therapy.
    Goodnough LT; Hill CC
    Transfusion; 2012 May; 52 Suppl 1():56S-64S. PubMed ID: 22578372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective fresh frozen plasma in the critically ill: what is the evidence?
    Verghese SG
    Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
    Abdel-Wahab OI; Healy B; Dzik WH
    Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Devine DV
    Transfusion; 2007 Apr; 47(4):749. PubMed ID: 17381637
    [No Abstract]   [Full Text] [Related]  

  • 8. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Cheng CK; Sadek I
    Transfusion; 2007 Apr; 47(4):748; author reply 749. PubMed ID: 17381635
    [No Abstract]   [Full Text] [Related]  

  • 9. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2007; ():179-86. PubMed ID: 18024627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding.
    Tinmouth A
    Transfus Apher Sci; 2012 Jun; 46(3):293-8. PubMed ID: 22521566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for indications of fresh frozen plasma.
    Stanworth SJ; Hyde CJ; Murphy MF
    Transfus Clin Biol; 2007 Dec; 14(6):551-6. PubMed ID: 18430602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Plasma for Acquired Coagulation Factor Deficiencies in Critical Care.
    Shah A; McKechnie S; Stanworth S
    Semin Thromb Hemost; 2016 Mar; 42(2):95-101. PubMed ID: 26716502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing response to changing plasma/red cell ratios in a bleeding trauma patient.
    Tien HC; Scarpellini S; Callum J; Tremblay L; Rizoli S
    Am J Emerg Med; 2010 Jan; 28(1):120.e1-5. PubMed ID: 20006235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood component support in acquired coagulopathic conditions: is there a method to the madness?
    Pandit TN; Sarode R
    Am J Hematol; 2012 May; 87 Suppl 1():S56-62. PubMed ID: 22473878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
    Gajic O; Dzik WH; Toy P
    Crit Care Med; 2006 May; 34(5 Suppl):S170-3. PubMed ID: 16617262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Plasma Transfusion: An Evidence-Based Review.
    Keir AK; Stanworth SJ
    Transfus Med Rev; 2016 Oct; 30(4):174-82. PubMed ID: 27473518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Algorithmic and consultative integration of transfusion medicine and coagulation: a personalized medicine approach with reduced blood component utilization.
    Brown RE; Dorion RP; Trowbridge C; Stammers AH; Fitt W; Davis J
    Ann Clin Lab Sci; 2011; 41(3):211-6. PubMed ID: 22075502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of clotting tests in the neonate.
    Pal S; Curley A; Stanworth SJ
    Arch Dis Child Fetal Neonatal Ed; 2015 May; 100(3):F270-4. PubMed ID: 25414486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of blood components in cancer patients with bleeding.
    Bodensteiner DC; Tilzer LL; Adams ME; Bayer WL
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1375-92. PubMed ID: 1452518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion support in acquired coagulation disorders.
    Phillips LL
    Clin Haematol; 1984 Feb; 13(1):137-50. PubMed ID: 6723119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.